Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Raphael Pharmaceutical Inc Com (New) (OTC : RAPH) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabidiol and oil. It develops product candidate for the treatment of rheumatoid arthritis, oncology indications, and hyper inflammatory syndrome inflammation related to COVID-19. Raphael Pharmaceutical Inc. is headquartered in Tel Aviv-Yafo, Israel.
Quote
| Last: | $1.40 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $1.4 |
| Close: | $1.40 |
| High: | $1.4 |
| Low: | $1.4 |
| Volume: | 228 |
| Last Trade Date Time: | 07/28/2026 11:53:26 am |
Stock Data
| Market Cap: | $27,476,985 |
|---|---|
| Float: | 9,028,152 |
| Insiders Ownership: | 8.29% |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | Pharmaceuticals |
| Sector: | Healthcare |
| Website: | https://www.raphaelpharmaceutical.com |
| Country: | IL |
| City: | Tel Aviv-Jaffa |
Recent News Releases
Subscribe to Our Newsletter
Message Board Posts
investorshub : Slojab
investorshub : AveragePenny
investorshub : Slojab
investorshub : Slojab
**MWN-AI FAQ is based on asking OpenAI questions about Raphael Pharmaceutical Inc Com (New) (OTC: RAPH).
